{"id":18540,"date":"2025-07-02T11:30:34","date_gmt":"2025-07-02T08:30:34","guid":{"rendered":"https:\/\/atostek.com\/partnering-for-precision-in-cancer-care-how-atostek-helped-empnia-develop-fda-cleared-emotus\/"},"modified":"2025-07-21T11:39:31","modified_gmt":"2025-07-21T08:39:31","slug":"partnering-for-precision-in-cancer-care-how-atostek-helped-empnia-develop-fda-cleared-emotus","status":"publish","type":"post","link":"https:\/\/atostek.com\/en\/partnering-for-precision-in-cancer-care-how-atostek-helped-empnia-develop-fda-cleared-emotus\/","title":{"rendered":"Partnering for Precision in Cancer Care: How Atostek Helped EmpNia Develop FDA-Cleared eMotus\u2122"},"content":{"rendered":"

EmpNia\u2019s newly FDA-cleared eMotus\u2122 system promises to transform respiratory motion tracking in radiation therapy \u2014 and Atostek is proud to have contributed as a key software development partner in this groundbreaking project.<\/strong><\/p>\n

When EmpNia set out to revolutionize respiratory motion management in radiation therapy, they had a clear mission: to create a solution that was simple, effective, and accessible across all clinical settings. Now, with FDA clearance for their flagship product eMotus\u2122<\/strong>, that mission is becoming reality \u2014 and Atostek is proud to have played a part in making it happen.<\/p>\n

A Novel Approach to a Critical Challenge<\/h2>\n

Respiratory motion is one of the most persistent challenges in delivering precise image-guided radiation therapy. Existing solutions are often difficult to use, disruptive to clinical workflows, and incompatible with many imaging and therapy systems. EmpNia\u2019s answer to these barriers is eMotus: a disposable sensor pad paired with intuitive software for real-time motion tracking \u2014 designed for universal compatibility, rapid setup, and cost-effectiveness.<\/p>\n

A Key Software Partner<\/h2>\n

Atostek was selected as one of EmpNia\u2019s core technology partners during the development of eMotus. Atostek\u2019s team focused on delivering high-reliability software that integrates seamlessly with clinical systems and hardware, while ensuring regulatory compliance and real-time performance. Working closely with EmpNia\u2019s expert team across time zones and development stages, the team helped turn a bold concept into a commercially viable and FDA-cleared product.<\/p>\n

\u201ceMotus posed a unique and rewarding challenge \u2014 combining demanding real-time performance with strict regulatory FDA Class II requirements. We’re proud to have supported EmpNia in building a product that now has the potential to truly improve cancer care.\u201d<\/em>
\n\u2014 Mika Torhola<\/strong>, Director, New Business, Atostek<\/p>\n

A Shared Commitment to Impact<\/h2>\n

EmpNia\u2019s launch from stealth mode and entry into the U.S. healthcare market marks a significant milestone \u2014 not only for their company, but for the future of motion management in radiation therapy.<\/p>\n

\u201cAtostek was a vital \u00a0partner in the development of the eMotus system. Their team brought deep technical knowledge, medical software experience, and a collaborative spirit that helped turn our vision into a cleared, market-ready product. It was a long road \u2014 and we travelled it well together.\u201d<\/em>
\n\u2014 Manojeet Bhattacharya<\/strong>, PhD, Founder & CEO, EmpNia Inc.<\/p>\n

\n

Founded in 2020 and headquartered in Minneapolis, Minnesota, EmpNia Inc. develops innovative, practical, and universally accessible medical technologies that solve persistent challenges in radiation therapy and diagnostic imaging. EmpNia\u2019s flagship product, eMotus, is an FDA-cleared disposable sensor pad that provides simple, effective respiratory motion management for precision radiation therapy in any clinical setting. For more information, please visit www.empnia.com<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

EmpNia\u2019s newly FDA-cleared eMotus\u2122 system promises to transform respiratory motion tracking in radiation therapy \u2014 and Atostek is proud to have contributed as a key software development partner in this groundbreaking project. When EmpNia set out to revolutionize respiratory motion management in radiation therapy, they had a clear mission: to create a solution that was…<\/p>\n","protected":false},"author":4,"featured_media":18536,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[31],"tags":[],"class_list":["post-18540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","entry","has-media"],"_links":{"self":[{"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/posts\/18540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/comments?post=18540"}],"version-history":[{"count":1,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/posts\/18540\/revisions"}],"predecessor-version":[{"id":18541,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/posts\/18540\/revisions\/18541"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/media\/18536"}],"wp:attachment":[{"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/media?parent=18540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/categories?post=18540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atostek.com\/en\/wp-json\/wp\/v2\/tags?post=18540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}